-+ 0.00%
-+ 0.00%
-+ 0.00%

Oncolytics Biotech names Steve Glover to board of directors

PUBT·06/02/2026 13:03:43
Listen to the news
Oncolytics Biotech names Steve Glover to board of directors
  • Oncolytics Biotech appointed Steve Glover to its board, adding transaction experience from his role as Ambrx Biopharma chairman during its ~USD 2 billion sale to Johnson & Johnson.
  • John McAdory was promoted to chief operating officer, taking oversight of clinical operations, development activities, preclinical R&D, strategic partnerships, and business development.
  • McAdory joined earlier this year from CG Oncology, where he served as vice president of clinical operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncolytics Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020900PRIMZONECNPR____9730198) on June 02, 2026, and is solely responsible for the information contained therein.